Navigation Links
DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza
Date:6/5/2009

Two timely sessions at the DIA 45th Annual Meeting reflect the state of today's global biopharmaceutical environment.

Horsham, PA, USA (Vocus) June 5, 2009 -- The Drug Information Association (DIA) 45th Annual Meeting is the biopharmaceutical industry's largest and longest running global, multidisciplinary conference featuring sessions and preconference tutorials on issues affecting drug discovery and development, including two timely sessions reflecting the state of today's global biopharmaceutical environment.

The public policy/law track features a special session on Labeling Risk: Practical Approaches after Wyeth v. Levine (June 22; 1:30 - 3:00 pm).

In March 2009, The Wall Street Journal reported that the Supreme Court ruling in Wyeth v. Levine stated that pharmaceutical companies are not necessarily shielded from failure to warn product liability lawsuits in state courts when the US FDA has determined that approved labeling appropriately explains risk information, This session will explore practical approaches pharmaceutical companies should consider when disseminating risk information to minimize failure to warn liability and to maximize the possibility such liability is preempted.

"We will delve deep into the legal benefits of preemptions, describe regulatory and documentation strategies that maximize the availability of preemption in failure-to-warn lawsuits, and identify effective risk communication strategies," says Session Chair Patrick C O'Brien, JD, PharmD, Partner, Burke O'Neil LLC, United States.

Speakers include:

 
  • John B Moriarty, JD, Senior Vice President, Elan Pharmaceuticals, United States
  • Sandra A. Milligan, JD, MD, Executive Director, Amgen Inc., United States
Mary K. Pendergast, JD, LLM, President, Pendergast Consulting, United States
This year's biotechnology track includes a timely session on Regulatory Methods to Facilitate the Approval of Biological Products to Address Pandemic Influenza (June 22, 1:30 - 3:00 pm).

This session incorporates descriptions of novel regulatory mechanisms for vaccine approval with a discussion of successful applications for pandemic influenza.

"This must-attend session will attempt to identify novel regulatory approaches to vaccine approval, industry approaches toward interactions with the FDA, and novel biochemical methods for the development of vaccines," explains Session Chair Richard M Lewis, PhD, CEO, Access BIO, United States.

Speakers include:

 
  • Jean L Hu-Primmer, MS, Program Manager, Pandemic and Emerging Threat Preparedness, OD, CBER, USFDA
  • John Purves, PhD, Head of Sector, Quality of Medicines, European Medicines Agency
  • Ozzie Berger, Senior Director and Head, Influenza Vaccines, US Regulatory Affairs, Biologicals, GlaxoSmithKline

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team.

Contact:
Joe Krasowski
+1-215-293-5812

Bonnie Shaw
Clearpoint Agency, Inc.
+1-858-724-2500

# # #

Read the full story at http://www.prweb.com/releases/DIA/45th_Annual_Meeting/prweb2502964.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Council of State and Territorial Epidemiologists Annual Conference Begins June 7 in Buffalo, NY
2. NeoGenomics to Present at Noble Financials 5th Annual Equity Conference on Monday, June 8th
3. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
4. NuVasive to Present at the 8th Annual Needham Life Sciences Conference
5. Maggianos Little Italy(R) Celebrates Sixth Annual Eat-A-Dish for Make-A-Wish(R) in Chicago
6. Trubion to Present at the 8th Annual Needham Life Sciences Conference
7. Photos: Tommy & Thalia Mottola Honored at 7th Annual FedEx/St. Jude Angels & Stars Gala
8. Accuray Incorporated to Present at Eighth Annual Needham Life Sciences Conference
9. Medivation to Present at 8th Annual Needham Life Sciences Conference
10. Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
11. Cepheid Announces Symposium Program for 2009 Association for Professionals in Infection Control (APIC) Annual Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DIA 45th Annual Meeting Features Sessions Highlighting Wyeth v. Levine and Pandemic Influenza 
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
Breaking Medicine Technology: